Partner Eli A. Loots, Ph.D. quoted in, “Will Inter Partes Review Go Away? Supreme Court Weighs Fate,” an article posted in Pink Sheet.
Excerpt: Biopharma and generic industries stand on opposing sides in case that could eliminate the patent challenge proceeding. Interactive timeline covers IPR’s five-year history leading to oral arguments Nov. 27.
Read Full Article Here >> (Subscription required)